Prevalence and predictors of insomnia and sleep medication use in a large tri-service US military sample

Objective: The presence of insomnia in the general military population is not well known. This study aimed to determine the prevalence of probable clinical insomnia and identify factors leading to new-onset insomnia and/or sleep medication use in a large military population. Design: Cross-sectional and longitudinal analyses of a prospective cohort study. Participants: A tri-service US military and veteran cohort (sample range 99,383-137,114). Measurements: Participants were surveyed in 2013 (Time 1 [T1]) and 2016 (Time 2 [T2]) using the clinically validated Insomnia Severity Index. The prevalence of insomnia and sleep medication use was quantified at both times. Multivariable models identified military factors associated with new-onset insomnia and/or sleep medication use while adjusting for covariates. Results: The prevalence of insomnia at T1 and T2 was 16.3% and 11.2%, respectively. New-onset insomnia at T2 was reported by 6.0% of participants screening negative at T1; risk factors included Army service, combat deployment experience, and separation from military service. The prevalence of sleep medication use at T1 and T2 was 23.1% and 25.1%, respectively. Sleep medication use at T2 was newly-reported by 17.1% of participants not reporting sleep medication use at T1; risk factors included number of deployments and having a healthcare occupation. Conclusions: The prevalence of probable clinical insomnia in this large general military population is within the range of previous reports in military and civilian populations. Certain military factors that predict new onset insomnia and/or sleep medication use should be considered when designing and implementing sleep interventions in military populations. Published by Elsevier Inc. on behalf of National Sleep Foundation. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)